Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL2993992 | 0.93 | ACHE (0.41) | ACHEHTTLMNAHPGDSMN1; SMN2 | |
| Sulfuric Acid SCHEMBL28771900 | 0.93 | ACHE (0.41) | ACHEHTTLMNAHPGDSMN1; SMN2 | |
| SCHEMBL1617829 | 0.91 | ACHE (0.40) | ACHEHTTLMNAHPGDSMN1; SMN2 | |
| SCHEMBL3003425 | 0.91 | ACHE (0.40) | ACHEHTTLMNAHPGDSMN1; SMN2 | |
| SCHEMBL2833385 | 0.87 | ACHE (0.40) | ACHEHTTLMNAHPGDSMN1; SMN2 | |
| Trifluoromethanesulfonic Acid SCHEMBL16398604 | 0.87 | ACHE (0.40) | ACHEHTTLMNAHPGDSMN1; SMN2 | |
| Trifluoromethanesulfonic Acid SCHEMBL1330268 | 0.87 | ACHE (0.40) | ACHEHTTLMNAHPGDSMN1; SMN2 | |
| SCHEMBL294564 | 0.85 | — | — | |
| SCHEMBL28394690 | 0.85 | ACHE (0.47) | ACHEHTTLMNAHPGDSMN1; SMN2 | |
| Bicarbonate SCHEMBL28771600 | 0.84 | LMNA (0.41) | ACHEHTTLMNAHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2721681-B1 | METHODS OF PRODUCING SULFATE SALTS OF CATIONS FROM HETEROATOMIC COMPOUNDS AND DIALKYL SULFATES AND USES THEREOF | NANTENERGY INC (US) | 2018-11-28 | — | — | EP | claimed |
| US-9147919-B2 | Methods of producing sulfate salts of cations from heteroatomic compounds and dialkyl sulfates and uses thereof | FLUIDIC, INC. (US) | 2015-09-29 | — | — | US | claimed |
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | claimed |
| US-20120323004-A1 | METHODS OF PRODUCING SULFATE SALTS OF CATIONS FROM HETEROATOMIC COMPOUNDS AND DIALKYL SULFATES AND USES THEREOF | FLUIDIC, INC. (US) | 2012-12-20 | — | — | US | claimed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | claimed |
| CN-111836849-B | Process for producing fibers, films and moldings of polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-3512905-B1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2022-08-24 | — | — | EP | disclosed |
| CN-109790292-B | Process for preparing polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-109415602-B | 2-cyanoacrylate-based adhesive composition | 东亚合成株式会社 | 2021-05-25 | — | — | CN | disclosed |
| EP-3762447-A1 | METHOD FOR PRODUCING FIBRES, FILMS AND MOULDED BODIES OF A POLYBENZAZOLE POLYMER (P) | BASF SE (DE) | 2021-01-13 | — | — | EP | disclosed |
| US-20200407508-A1 | METHOD FOR PRODUCING FIBERS, FILMS AND MOLDINGS OF A POLYBENZAZOLE POLYMER (P) | BASF SE (DE) | 2020-12-31 | — | — | US | disclosed |
| CN-111836849-A | Process for producing fibers, films and moldings of polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2020-10-27 | — | — | CN | disclosed |
| EP-2721681-B1 | METHODS OF PRODUCING SULFATE SALTS OF CATIONS FROM HETEROATOMIC COMPOUNDS AND DIALKYL SULFATES AND USES THEREOF | NANTENERGY INC (US) | 2018-11-28 | — | — | EP | disclosed |
| EP-3336962-A1 | ELECTROCHEMICAL CELL COMPRISING ELECTROLYTE HAVING HETERO IONIC COMPLEX | Fluidic, Inc. (US) | 2018-06-20 | — | — | EP | disclosed |
| US-9793586-B2 | Synthesis of hetero compounds using dialkylcarbonate quaternation | FLUIDIC, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| CN-104640947-B | 2 cyanoacrylate system adhesive compositions | 东亚合成株式会社 | 2017-10-03 | — | — | CN | disclosed |
| US-9147919-B2 | Methods of producing sulfate salts of cations from heteroatomic compounds and dialkyl sulfates and uses thereof | FLUIDIC, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-20120323004-A1 | METHODS OF PRODUCING SULFATE SALTS OF CATIONS FROM HETEROATOMIC COMPOUNDS AND DIALKYL SULFATES AND USES THEREOF | FLUIDIC, INC. (US) | 2012-12-20 | — | — | US | disclosed |
| US-7897806-B2 | Reacting primary amines with phosgene in ionic liquid as solvent | BASF AKTIENGESELLSCHAFT (DE) | 2011-03-01 | — | — | US | disclosed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | PGLS, INMT, PNMT | ACHE 796/4885HTT 1805/4885LMNA 1276/4885 |
| US-20120323004-A1 | METHODS OF PRODUCING SULFATE SALTS OF CATIONS FROM HETEROATOMIC COMPOUNDS AND DIALKYL SULFATES AND USES THEREOF | TST, STS, SCLY | ACHE 1683/4885HTT 1461/4885LMNA 4099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.